PRF Technologies (PRFX) vs SciSparc (SPRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
PRF Technologies is the larger company by market cap ($3.0 million vs $2.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | PRFX | SPRC |
|---|---|---|
| Share price | $0.8587 | $4.43 |
| Market cap | $3.00M | $2.57M |
| 1-day change | -2.16% | -4.53% |
| P/E ratio (TTM) | — | 0.02 |
| EPS (TTM) | $-4.09 | $248.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $43.65 |
| 52-week low | $0.8511 | $2.98 |
| Distance from 52-week high | -89.20% | -89.85% |
| Average volume | 298.86K | 180.20K |
| Shares outstanding | 3.50M | 580.97K |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
PRFX vs SPRC FAQ
Which is bigger, PRF Technologies or SciSparc?
PRF Technologies (PRFX) is larger, with a market capitalization of $3.00M compared with $2.57M for SciSparc (SPRC).
Are PRF Technologies and SciSparc in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.